Peptides for Immune Monitoring

Peptide-based immune monitoring is essential for assessing cellular immune responses, particularly in vaccine development and cancer immunotherapy. JPT’s peptide offerings support a wide range of studies focused on immune activation, T cell responses, and monitoring the efficacy of immunotherapies. Below, you will find key studies referencing JPT’s peptides for immune monitoring.

References with Peptides for Immune Monitoring

Cellular Immune Monitoring

The HDAC inhibitor zabadinostat is a systemic regulator of adaptive immunity
Liu et al., Communications Biology (2023)
SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals
Emmelot et al., Viruses (2023)
Single-dose YF17D-vectored Ebola vaccine candidate protects mice against both lethal surrogate Ebola and yellow fever virus challenge
Lemmens et al., BioRxiv (2023)
Diminished responses to mRNA-based SARS-CoV-2 vaccines in individuals with rheumatoid arthritis on immune modifying therapies
Klebanoff et al., MedRxiv (2023)
The prospect of universal coronavirus immunity: a characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses
Soni et al., BioRxiv (2023)
Immunogenicity and safety of a two-dose regimen with hepatitis E virus vaccine in healthy adults in rural Bangladesh: A randomized, double-blind, controlled, phase 2/pilot trial
Øverbø et al., Vaccine (2023)
Age-related Differences in Immune Reactions to SARS-CoV-2 Spike and Nucleocapsid Antigens
Morhart et al,. Vaccines (2023)
Listeria-vectored multi-antigenic tuberculosis vaccine protects C57BL/6 and BALB/c mice and guinea pigs against Mycobacterium tuberculosis challenge
Jia et al., Communications Biology (2022)
Accelerated waning of immune responses to a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases
Mrak et al., Journal of Autoimmunity (2022)
Humoral and Cellular Responses to a Delayed Fourth SARS-CoV-2 mRNA-Based Vaccine in Weak Responders to 3 Doses Kidney Transplant Recipients
Del Bello et al., Vaccines (2022) - PMID: 36146517

Humoral Immune Monitoring

Immunotherapy-induced neutralizing antibodies disrupt allergen binding and sustain allergen tolerance in peanut allergy
LaHood et al., Journal of Clinical Investigation (2023) - PMID: 36647835
The regulatory role of the CD2AP/TKS4 interaction in EMT and its potential as a biomarker for colon cancer
Kurilla et al., BioRxiv (2023)
Human antibody profling technologies for autoimmune disease
Carlton et al., Immunologic Research (2022)
Immunotherapy-induced neutralizing antibodies disrupt allergen binding and sustain allergen tolerance in peanut allergy
LaHood et al., Journal of Clinical Investigation (2023) - PMID: 36647835
Antibody landscape of C57BL/6 mice cured of B78 melanoma via immunotherapy
Hoefges et al., BioRxiv (2023)
Immune profling of SARS-CoV-2 epitopes in asymptomatic and symptomatic pediatric and adult patients
Tornesello et al., Journal of Translational Medicine (2023)
Basal diet composition contributes to differential performance, intestinal health, and immunological responses to a microalgae-based feed ingredient in broiler chickens
Fries-Craft et al., Poultry Science (2022)
Treatment of Long COVID with nirmatrelvir/ritonavir and tocilizumab in a patient with rheumatoid arthritis and SARS-CoV-2 antigen persistence: a case report
Visvabharathy et al., Research Square (2022)
A single intranasal dose of human parainfluenza virus type 3-vectored vaccine induces effective antibody and memory T cell response in the lungs and protects hamsters against SARS-CoV-2
Ilinykh et al., Vaccines (2022)
Co-Administration of Adjuvanted Recombinant Ov-103 and Ov-RAL-2 Vaccines Confer Protection against Natural Challenge in A Bovine Onchocerca ochengi Infection Model of Human Onchocerciasis
Luu et al., Vaccines (2022)
High‑resolution analysis of long‑term serum antibodies in humans following convalescence of SARS‑CoV‑2 infection
Facciuolo et al., Scientific Reports (2022)

Immune Monitoring